Thursday, 18 May 2017

Drug pricing regulator clamps down on drug cocktails

Get Free Daily Intraday Tips and more >>

India's drug pricing regulator has issued a notice seeking an explanation from companies found to be selling new versions of essential medicines without government approval on their pricing, a statement released on its website late on Wednesday showed.

The move could result in penalties for several drugmakers and is the latest in a series of recent actions by India's National Pharmaceutical Pricing Authority (NPPA) towards tightening control of drug prices.

More than 300 medicines that India defines as essential are currently under a government price cap, and the law requires companies to seek approval of the NPPA before launching new dosage forms or combinations of such drugs.

No comments:

Post a Comment